Skip to main content
Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.
Preclinical efficacy of MEK inhibition in Nras-mutant AML.
NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia.
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/Cernunnos deficiency.
A(nother) RAF mutation in LCH.
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.
Mutations in GATA2 are rare in juvenile myelomonocytic leukemia.
Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.